January 30, 2023
For three active pharmaceutical ingredients (Atracurium Besylate, Biperiden HCl, Cisatracurium Besylate) we plan to develop a manufacturing technology first on laboratory scale followed by pilot plant and finally on production scale. The quality of the pharmaceutical...
January 30, 2023
A Cf Pharma exclusive commercial partner, Patriapharma won the below grant for establishing its Japanese subsidiary: The project “Establishment of a representative office in Japan to increase the volume of trade with Asian countries” was funded by the Ministry of...
January 6, 2023
We have started the new year with welcoming Mr. Alex Gruman into the Business development director role. Alex will share his 35+ years experience in pharma business where he served different CDMOs as managing director as well as his long period within Rhone Poulenc...
December 1, 2022
Due to the Covid-pandemic a large volume of Atracurium was needed worldwide. Government agencies and private companies ordered huge amounts from the API. Atracurium is a muscle-relaxant mostly used for respiratory infections during the anesthesia procedure. It was a...
November 15, 2022
Successful renewal of the GMP Certificate for CF Pharma Ltd. Three members from the National Institute of Pharmacy (Hungarian: Országos Gyógyszerészeti Intézet, known as: „OGYI”) audited our companies for GMP compliance on 5 APIs (Atracurium besylate, Cabergoline,...
November 1, 2022
Our company was represented on the CPHI Worldwide in Frankfurt. This was the first major pharmaceutical global event after the Covid pandemic, which was held live. It was a great pleasure to meet with new clients and discuss current and future business...
